hydroxyurea has been researched along with Nerve Pain in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Significantly more patients with neuropathic pain were taking hydroxyurea (90% vs." | 1.40 | Neuropathic pain in patients with sickle cell disease. ( Brandow, AM; Farley, RA; Panepinto, JA, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antunes, FD | 1 |
Propheta, VGS | 1 |
Vasconcelos, HA | 1 |
Cipolotti, R | 1 |
Brandow, AM | 1 |
Farley, RA | 1 |
Panepinto, JA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Safety and Feasibility of High-Dose Topical Capsaicin for the Treatment of Neuropathic Pain in Pediatric Sickle Cell Disease[NCT03899246] | Phase 1 | 10 participants (Actual) | Interventional | 2019-07-03 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 other studies available for hydroxyurea and Nerve Pain
Article | Year |
---|---|
Neuropathic pain in patients with sickle cell disease: a cross-sectional study assessing teens and young adults.
Topics: Adolescent; Adult; Analysis of Variance; Anemia, Sickle Cell; Antisickling Agents; Chi-Square Distri | 2017 |
Neuropathic pain in patients with sickle cell disease.
Topics: Adolescent; Adult; Age Factors; Anemia, Sickle Cell; Cross-Sectional Studies; Female; Humans; Hydrox | 2014 |